Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
äŒæ¥ã³ãŒãEVGN
äŒç€ŸåEvogene Ltd
äžå Žæ¥Jun 11, 2007
æé«çµå¶è²¬ä»»è
ãCEOãEmber (Brian)
åŸæ¥å¡æ°117
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Jun 11
æ¬ç€Ÿæåšå°13 Gad Feinstein Street
éœåžREHOVOT
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœIsrael
éµäŸ¿çªå·7638517
é»è©±çªå·97289311900
ãŠã§ããµã€ãhttps://evogene.com/
äŒæ¥ã³ãŒãEVGN
äžå Žæ¥Jun 11, 2007
æé«çµå¶è²¬ä»»è
ãCEOãEmber (Brian)